No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

Gandhi, Rajesh T.
McMahon, Deborah K.
Bosch, Ronald J.
Lalama, Christina M.
Cyktor, Joshua C.
Macatangay, Bernard J.
Rinaldo, Charles R.
Riddler, Sharon A.
Hogg, Evelyn
Godfrey, Catherine
Collier, Ann C.
Eron, Joseph J.
Mellors, John W.

January 2017

Antiretroviral therapy (ART) reduces levels of HIV-1 and immune activation but both can persist desp...

A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal

Cd T Cell Response
Steven G. Deeks

October 2016

(See the article by Schulze zur Wiesch et al., on pages 894–7.) Background. Some human immunodeficie...

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

Darcis, Gilles
Berkhout, B.
Pasternak, A. O.

January 2020

peer reviewedIn adherent individuals, antiretroviral therapy (ART) suppresses HIV replication, resto...

No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

Gandhi, Rajesh T.
Coombs, Robert W.
Chan, Ellen S.
Bosch, Ronald J.
Zheng, Lu
Margolis, David M.
Read, Sarah
Kallungal, Beatrice
Chang, Ming
Goecker, Erin A.
Wiegand, Ann
Kearney, Mary
Jacobson, Jeffrey M.
DʼAquila, Richard
Lederman, Michael M.
Mellors, John W.
Eron, Joseph J.

January 2012

Controversy continues regarding the extent of ongoing viral replication in HIV-1-infected patients o...

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

Gandhi, Rajesh T.
Zheng, Lu
Bosch, Ronald J.
Chan, Ellen S.
Margolis, David M.
Read, Sarah
Kallungal, Beatrice
Palmer, Sarah
Medvik, Kathy
Lederman, Michael M.
Alatrakchi, Nadia
Jacobson, Jeffrey M.
Wiegand, Ann
Kearney, Mary
Coffin, John M.
Mellors, John W.
Eron, Joseph J.

January 2010

Most HIV-1-infected patients on effective antiretroviral therapy (ART) with plasma HIV-1 RNA levels ...

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: A randomized controlled trial

Gandhi, RT
Zheng, L
Bosch, RJ
Chan, ES
Margolis, DM
Read, S
Kallungal, B
Palmer, S
Medvik, K
Lederman, MM
Alatrakchi, N
Jacobson, JM
Wiegand, A
Kearney, M
Coffin, JM
Mellors, JW
Eron, JJ

August 2010

Background:Most HIV-1-infected patients on effective antiretroviral therapy (ART) with plasma HIV-1 ...

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.

Gandhi, Rajesh T
Zheng, Lu
Bosch, Ronald J
Chan, Ellen S
Margolis, David M
Read, Sarah
Kallungal, Beatrice
Palmer, Sarah
Medvik, Kathy
Lederman, Michael M
Alatrakchi, Nadia
Jacobson, Jeffrey M
Wiegand, Ann
Kearney, Mary
Coffin, John M
Mellors, John W.
Eron, Joseph J

August 2010

BACKGROUND: Most HIV-1-infected patients on effective antiretroviral therapy (ART) with plasma HIV-1...

Correspondence Short-course Raltegravir Intensification Does Not Increase 2 Long Terminal Repeat Episomal HIV-1 DNA in Patients on Effective

Antiretroviral Therapy

September 2016

To the Editor—Controversy exists about whether human immunodeficiency virus type 1 (HIV-1) replicati...

Transcriptional Changes in CD8+ T Cells During Antiretroviral Therapy Intensified With Raltegravir

Ouyang, Zhengyu
Buzon, Maria J.
Zheng, Lu
Sun, Hong
Yu, Xu G.
Bosch, Ronald J.
Mellors, John W.
Eron, Joseph J.
Gandhi, Rajesh T.
Lichterfeld, Mathias

January 2015

Background. Intensification of antiretroviral therapy with raltegravir does not affect levels of res...

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA

Bianco, Claudia
Meini, Genny
Rossetti, Barbara
Lamonica, Silvia
Mondi, Annalisa
Belmonti, Simone
Fanti, Luri
Ciccarelli, Nicoletta
Di Giambenedetto, Simona
Zazzi, Maurizio
De Luca, Andrea

January 2014

Raltegravir intensification is associated with an increase in 2-LTR episomal HIV DNA= circles, indic...

The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial

Rasmussen, TA
McMahon, JH
Chang, JJ
Audsley, J
Rhodes, A
Tennakoon, S
Dantanarayana, A
Spelman, T
Schmidt, T
Kent, SJ
Morcilla, V
Palmer, S
Elliott, JH
Lewin, SR

May 2018

BACKGROUND: Whether ongoing virus replication occurs in HIV-infected individuals on antiretroviral t...

Switching Virally Suppressed, Treatment-Experienced Patients to a Raltegravir-Containing Regimen Does Not Alter Levels of HIV-1 DNA

Lam Yu Ming Paul
McBride Kristin L.
Amin Janaki
Cordery Damien V.
Kelleher Anthony D.
Cooper David A.
Koelsch Kersten K.

March 2012

Current HIV-1 antiretroviral therapy (ART) greatly reduces virus replication but does not significan...

Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA.

Yu Ming Paul Lam
Kristin L McBride
Janaki Amin
Damien V Cordery
Anthony D Kelleher
David A Cooper
Kersten K Koelsch

BACKGROUND: Current HIV-1 antiretroviral therapy (ART) greatly reduces virus replication but does no...

Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection

Archin, Nancie M.
Cheema, Manzoor
Parker, Daniel
Wiegand, Ann
Bosch, Ronald J.
Coffin, John M.
Eron, Joseph
Cohen, Myron
Margolis, David M.

January 2010

BackgroundHuman immunodeficiency virus (HIV) infection that persists despite antiretroviral therapy ...

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Hatano, Hiroyu
Strain, Matthew
Wentworth, Deborah
Hoh, Rebecca
Neaton, James
Tracy, Russell
Hsue, Priscilla
Martin, Jeffrey
Deeks, Steven
Bacchetti, Peter
Mccune, Joseph
Richman, Douglas
Scherzer, Rebecca

November 2013

BACKGROUND: The degree to which human immunodeficiency virus (HIV) continues to replicate during ant...

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

Gandhi, Rajesh T.
McMahon, Deborah K.
Bosch, Ronald J.
Lalama, Christina M.
Cyktor, Joshua C.
Macatangay, Bernard J.
Rinaldo, Charles R.
Riddler, Sharon A.
Hogg, Evelyn
Godfrey, Catherine
Collier, Ann C.
Eron, Joseph J.
Mellors, John W.

January 2017

Antiretroviral therapy (ART) reduces levels of HIV-1 and immune activation but both can persist desp...

A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal

Cd T Cell Response
Steven G. Deeks

October 2016

(See the article by Schulze zur Wiesch et al., on pages 894–7.) Background. Some human immunodeficie...

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

Darcis, Gilles
Berkhout, B.
Pasternak, A. O.

January 2020

peer reviewedIn adherent individuals, antiretroviral therapy (ART) suppresses HIV replication, resto...

No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

Gandhi, Rajesh T.
Coombs, Robert W.
Chan, Ellen S.
Bosch, Ronald J.
Zheng, Lu
Margolis, David M.
Read, Sarah
Kallungal, Beatrice
Chang, Ming
Goecker, Erin A.
Wiegand, Ann
Kearney, Mary
Jacobson, Jeffrey M.
DʼAquila, Richard
Lederman, Michael M.
Mellors, John W.
Eron, Joseph J.

January 2012

Controversy continues regarding the extent of ongoing viral replication in HIV-1-infected patients o...

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

Gandhi, Rajesh T.
Zheng, Lu
Bosch, Ronald J.
Chan, Ellen S.
Margolis, David M.
Read, Sarah
Kallungal, Beatrice
Palmer, Sarah
Medvik, Kathy
Lederman, Michael M.
Alatrakchi, Nadia
Jacobson, Jeffrey M.
Wiegand, Ann
Kearney, Mary
Coffin, John M.
Mellors, John W.
Eron, Joseph J.

January 2010

Most HIV-1-infected patients on effective antiretroviral therapy (ART) with plasma HIV-1 RNA levels ...

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: A randomized controlled trial

Gandhi, RT
Zheng, L
Bosch, RJ
Chan, ES
Margolis, DM
Read, S
Kallungal, B
Palmer, S
Medvik, K
Lederman, MM
Alatrakchi, N
Jacobson, JM
Wiegand, A
Kearney, M
Coffin, JM
Mellors, JW
Eron, JJ

August 2010

Background:Most HIV-1-infected patients on effective antiretroviral therapy (ART) with plasma HIV-1 ...

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.

Gandhi, Rajesh T
Zheng, Lu
Bosch, Ronald J
Chan, Ellen S
Margolis, David M
Read, Sarah
Kallungal, Beatrice
Palmer, Sarah
Medvik, Kathy
Lederman, Michael M
Alatrakchi, Nadia
Jacobson, Jeffrey M
Wiegand, Ann
Kearney, Mary
Coffin, John M
Mellors, John W.
Eron, Joseph J

August 2010

BACKGROUND: Most HIV-1-infected patients on effective antiretroviral therapy (ART) with plasma HIV-1...

Correspondence Short-course Raltegravir Intensification Does Not Increase 2 Long Terminal Repeat Episomal HIV-1 DNA in Patients on Effective

Antiretroviral Therapy

September 2016

To the Editor—Controversy exists about whether human immunodeficiency virus type 1 (HIV-1) replicati...

Transcriptional Changes in CD8+ T Cells During Antiretroviral Therapy Intensified With Raltegravir

Ouyang, Zhengyu
Buzon, Maria J.
Zheng, Lu
Sun, Hong
Yu, Xu G.
Bosch, Ronald J.
Mellors, John W.
Eron, Joseph J.
Gandhi, Rajesh T.
Lichterfeld, Mathias

January 2015

Background. Intensification of antiretroviral therapy with raltegravir does not affect levels of res...

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA

Bianco, Claudia
Meini, Genny
Rossetti, Barbara
Lamonica, Silvia
Mondi, Annalisa
Belmonti, Simone
Fanti, Luri
Ciccarelli, Nicoletta
Di Giambenedetto, Simona
Zazzi, Maurizio
De Luca, Andrea

January 2014

Raltegravir intensification is associated with an increase in 2-LTR episomal HIV DNA= circles, indic...

The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial

Rasmussen, TA
McMahon, JH
Chang, JJ
Audsley, J
Rhodes, A
Tennakoon, S
Dantanarayana, A
Spelman, T
Schmidt, T
Kent, SJ
Morcilla, V
Palmer, S
Elliott, JH
Lewin, SR

May 2018

BACKGROUND: Whether ongoing virus replication occurs in HIV-infected individuals on antiretroviral t...

Switching Virally Suppressed, Treatment-Experienced Patients to a Raltegravir-Containing Regimen Does Not Alter Levels of HIV-1 DNA

Lam Yu Ming Paul
McBride Kristin L.
Amin Janaki
Cordery Damien V.
Kelleher Anthony D.
Cooper David A.
Koelsch Kersten K.

March 2012

Current HIV-1 antiretroviral therapy (ART) greatly reduces virus replication but does not significan...

Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA.

Yu Ming Paul Lam
Kristin L McBride
Janaki Amin
Damien V Cordery
Anthony D Kelleher
David A Cooper
Kersten K Koelsch

BACKGROUND: Current HIV-1 antiretroviral therapy (ART) greatly reduces virus replication but does no...

Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection

Archin, Nancie M.
Cheema, Manzoor
Parker, Daniel
Wiegand, Ann
Bosch, Ronald J.
Coffin, John M.
Eron, Joseph
Cohen, Myron
Margolis, David M.

January 2010

BackgroundHuman immunodeficiency virus (HIV) infection that persists despite antiretroviral therapy ...

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Hatano, Hiroyu
Strain, Matthew
Wentworth, Deborah
Hoh, Rebecca
Neaton, James
Tracy, Russell
Hsue, Priscilla
Martin, Jeffrey
Deeks, Steven
Bacchetti, Peter
Mccune, Joseph
Richman, Douglas
Scherzer, Rebecca

November 2013

BACKGROUND: The degree to which human immunodeficiency virus (HIV) continues to replicate during ant...

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

Gandhi, Rajesh T.
McMahon, Deborah K.
Bosch, Ronald J.
Lalama, Christina M.
Cyktor, Joshua C.
Macatangay, Bernard J.
Rinaldo, Charles R.
Riddler, Sharon A.
Hogg, Evelyn
Godfrey, Catherine
Collier, Ann C.
Eron, Joseph J.
Mellors, John W.

January 2017

Antiretroviral therapy (ART) reduces levels of HIV-1 and immune activation but both can persist desp...

A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal

Cd T Cell Response
Steven G. Deeks

October 2016

(See the article by Schulze zur Wiesch et al., on pages 894–7.) Background. Some human immunodeficie...

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

Darcis, Gilles
Berkhout, B.
Pasternak, A. O.

January 2020

peer reviewedIn adherent individuals, antiretroviral therapy (ART) suppresses HIV replication, resto...

No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

Abstract

Extracted data

No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

Abstract

Extracted data

Topics

Related items

Topics

Related items